Fentanyl
Capture and Detection of Aerosolized Fentanyl in a Suspended Electrochemical Cell
Detecting Fentanyl Use Through Court-Ordered Mandatory Drug Testing
Medetomidine Infiltrates the US Illicit Opioid Market
Using Intelligence Analysis to Understand and Address Fentanyl Distribution Networks in America’s Largest Port City
Evaluating Cross-reactivity of New Psychoactive Substances (NPS) in Human Whole Blood by Enzyme-linked Immunosorbent Assay (ELISA)
Prevalence of Fentanyl and Its Analogues in a Court-Ordered Mandatory Drug Testing Population
Aptamer-Based Fentanyl Detection in Biological Fluids
Targeted Fentanyl Screening Utilizing Electrochemical Surface-Enhanced Raman Spectroscopy (EC-SERS) Applied to Authentic Seized Drug Casework Samples
Evaluation and Classification of Fentanyl Related Compounds using EC-SERS and Machine Learning
Gas Chromatography With Tandem Cold Electron Ionization Mass Spectrometric Detection and Vacuum Ultraviolet Detection for the Comprehensive Analysis of Fentanyl Analogues
Data-Independent Screening Method for 14 Fentanyl Analogs in Whole Blood and Oral Fluid Using LC-QTOF-MS
An interlaboratory study to evaluate the utility of gas chromatography-mass spectrometry and gas chromatography-infrared spectroscopy spectral libraries in the forensic analysis of fentanyl-related substances
A Data-Informed Response to Emerging Drugs
The emerging drug crisis in the U.S. touches both criminal justice and public health, and experts from both fields came together at NIJ’s 2023 National Research Conference to discuss strategies and tools to fight this problem. Dr. Frances Scott, NIJ scientist and program manager, continues the conference discussion with two fellow panelists: Ciena Bayard, the Method Development and Validation Program Manager for D.C. Office of the Chief Medical Examiner, and Haley Greene, the Deputy Epidemiologist for the Central Region for the Virginia Department of Health. Read the transcript.